Paul A Tambyah
Overview
Explore the profile of Paul A Tambyah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
142
Citations
3183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goh W, Soo M, Lye P, Tan S, Tambyah P
Int J STD AIDS
. 2024 Sep;
35(14):1176-1179.
PMID: 39264877
Background: Kikuchi-Fujimoto lymphadenitis (or histiocytic necrotising lymphadenitis) is a rare disease that is usually benign and self-limiting. A higher prevalence is reported amongst East Asian populations. No clear etiology has...
2.
Mahyuddin A, Swa H, Weng R, Zhang J, Dhanaraj J, Sesurajan B, et al.
Int J Infect Dis
. 2024 Jun;
146:107121.
PMID: 38823622
Objectives: To investigate multi-dose and timings of COVID-19 vaccines in preventing antenatal infection. Design: Prospective observational study investigating primary vaccinations, boosters, antenatal COVID-19 infections, neutralizing antibody (Nab) durability, and cross-reactivity...
3.
Chew C, Young B, Tambyah P, Vasoo S, Chan C
Influenza Other Respir Viruses
. 2024 Mar;
18(3):e13266.
PMID: 38462553
No abstract available.
4.
Gu Y, Shunmuganathan B, Qian X, Gupta R, Tan R, Kozma M, et al.
Sci Rep
. 2023 Dec;
13(1):21810.
PMID: 38071323
The scale and duration of neutralizing antibody responses targeting SARS-CoV-2 viral variants represents a critically important serological parameter that predicts protective immunity for COVID-19. In this study, we describe the...
5.
Tan E, Lim W, Thong E, Chavatte J, Zhang J, Lim J, et al.
Transplant Direct
. 2023 Sep;
9(10):e1537.
PMID: 37745946
Background: Immunocompromised individuals have been excluded from landmark studies of messenger RNA vaccinations for severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). In such patients, the response to vaccination may...
6.
Chye D, Chew C, Yeo H, Tambyah P, Young B, Tan G, et al.
J Med Virol
. 2023 Sep;
95(9):e29074.
PMID: 37665160
No abstract available.
7.
Lu L, Chan C, Chan-Ng P, Than M, Tan P, Lim L, et al.
Clin Transl Med
. 2023 Jan;
13(1):e1183.
PMID: 36658466
No abstract available.
8.
Goh Y, Fong S, Hor P, Amrun S, Lee C, Young B, et al.
Front Microbiol
. 2022 Dec;
13:1043049.
PMID: 36483199
Introduction: COVID-19 has a wide disease spectrum ranging from asymptomatic to severe. While humoral immune responses are critical in preventing infection, the immune mechanisms leading to severe disease, and the...
9.
Cross G, Naftalin C, Ngiam J, Bagdasarian N, Poh C, Goh Y, et al.
J Med Virol
. 2022 Feb;
94(6):2460-2470.
PMID: 35171507
Coronavirus Disease 2019 (COVID-19) serology has an evolving role in the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, its use in hospitalized patients with acute respiratory...
10.
Chan A, Tan B, Goh Y, Tan S, Tambyah P
Brain Behav Immun Health
. 2021 Dec;
19:100406.
PMID: 34927105
The COVID-19 pandemic has had an unprecedented impact on healthcare systems globally, giving rise to significant morbidity and mortality. Vaccination has been widely regarded as the most important strategy to...